Cargando…
Large-scale tumor-associated collagen signatures identify high-risk breast cancer patients
The notion of personalized medicine demands proper prognostic biomarkers to guide the optimal therapy for an invasive breast cancer patient. However, various risk prediction models based on conventional clinicopathological factors and emergent molecular assays have been frequently limited by either...
Autores principales: | Xi, Gangqin, Guo, Wenhui, Kang, Deyong, Ma, Jianli, Fu, Fangmeng, Qiu, Lida, Zheng, Liqin, He, Jiajia, Fang, Na, Chen, Jianhua, Li, Jingtong, Zhuo, Shuangmu, Liao, Xiaoxia, Tu, Haohua, Li, Lianhuang, Zhang, Qingyuan, Wang, Chuan, Boppart, Stephen A., Chen, Jianxin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847696/ https://www.ncbi.nlm.nih.gov/pubmed/33537084 http://dx.doi.org/10.7150/thno.55921 |
Ejemplares similares
-
Computer-assisted quantification of tumor-associated collagen signatures to improve the prognosis prediction of breast cancer
por: Xi, Gangqin, et al.
Publicado: (2021) -
Intratumor graph neural network recovers hidden prognostic value of multi-biomarker spatial heterogeneity
por: Qiu, Lida, et al.
Publicado: (2022) -
Prognostic value of tumor necrosis based on the evaluation of frequency in invasive breast cancer
por: Chen, Jianhua, et al.
Publicado: (2023) -
Multimodal multiphoton imaging for label-free monitoring of early gastric cancer
por: Li, Lianhuang, et al.
Publicado: (2019) -
Label-free multiphoton imaging to assess neoadjuvant therapy responses in breast carcinoma
por: Li, Lianhuang, et al.
Publicado: (2020)